ShareThis Page
Friends in high office |

Friends in high office

| Wednesday, March 28, 2007 12:00 a.m

Our wonderful senators Arlen Specter (R) and Bob Casey (D) can sure see eye to eye (nonpartisan) when it comes to supporting the less fortunate (Roll Call, “Medicare drug premiums,” March 25).

They both just couldn’t see increasing the Medicare Prescription Drug program premium for those making over $80,000 individually and couples over $160,000. (Both voted no in the Senate’s 44-52 defeat of the bill.)

What a slap in the face to the majority of Pennsylvanians, especially those who are retired or soon will retire with limited pensions. That is, of course, with the exception of the members of the Pennsylvania Legislature and their staff and state authorities, who exceed these levels dramatically.

We are in big trouble, as we have no friends in the Legislature or the federal government. With more egregious examples such as these from Specter and Casey we could soon be wishing for Santorum to return.

Nelson TonetPine

Categories: News
TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.